Effect of Reducing Inflammation of Coptis chinensis Extract -Ceramide Complex through ECS Control in Atopic Dermatitis
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- KCI
- 저널 순위
- KCI Q1
- 저널
- 대한한의학회지42(4) · pp.207 · 2021
- 피인용
- KCI 0
- ISSN
- 1010-0695
저자
초록
Objectives: Objective: The purpose of this study was to confirm effect of reducing inflammation of Coptis chinensis extract -ceramide complex through the endocannabinoid system (ECS) control in atopic dermatitis. Methods: 8-week-old ICR mice were divided into normal group (Ctrl), lipid barrier elimination group (ADE), palmitoylethanolamide treated group after lipid barrier elimination (PEAT), and Coptis chinensis extract-ceramide complex applied group after lipid barrier elimination (CRA). After inducing atopic dermatitis, cannabinoid receptor (CB) 1, CB2, CD68, p-IκB, iNOS, substance P and serotonin were observed to confirm the regulation of the ECS, macrophage activity and mast cell activity. Results: CB1 and CB2 showed higher positive reactions in the CRA than in the ADE and PEAT. CD68, p-IκB and iNOS showed higher positive reaction in the ADE, PEAT and CRA than in the Ctrl, but the increase in the positive reaction was lower in the CEA compared to the ADE and PEAT. Substance P and serotonin showed higher positive reaction in the ADE, PEAT and CRA than in the Ctrl, but the increase in the positive reaction was lower in the CEA compared to the ADE and PEAT. Conclusions: The effects of Coptis chinensis extract -ceramide complex were confirmed on the regulation of the ECS, macrophage activity and mast cell activity.
키워드
Coptis chinensisAtopic dermatitisCeramideEndocannabinoid system (ECS)CB1CB2
식별자
- KCI
- ART002781386



로그인
연구물 목록으로